|
International Journal of Computer Applications
Foundation of Computer Science (FCS), NY, USA
|
| Volume 187 - Issue 78 |
| Published: February 2026 |
| Authors: Soumya Pal, Kakali Datta, Debarka Mukhopadhyay, Paramartha Dutta |
10.5120/ijca2026926333
|
Soumya Pal, Kakali Datta, Debarka Mukhopadhyay, Paramartha Dutta . Multi-Disease Detection and Classification Using a Lightweight Convolutional Neural Network. International Journal of Computer Applications. 187, 78 (February 2026), 11-23. DOI=10.5120/ijca2026926333
@article{ 10.5120/ijca2026926333,
author = { Soumya Pal,Kakali Datta,Debarka Mukhopadhyay,Paramartha Dutta },
title = { Multi-Disease Detection and Classification Using a Lightweight Convolutional Neural Network },
journal = { International Journal of Computer Applications },
year = { 2026 },
volume = { 187 },
number = { 78 },
pages = { 11-23 },
doi = { 10.5120/ijca2026926333 },
publisher = { Foundation of Computer Science (FCS), NY, USA }
}
%0 Journal Article
%D 2026
%A Soumya Pal
%A Kakali Datta
%A Debarka Mukhopadhyay
%A Paramartha Dutta
%T Multi-Disease Detection and Classification Using a Lightweight Convolutional Neural Network%T
%J International Journal of Computer Applications
%V 187
%N 78
%P 11-23
%R 10.5120/ijca2026926333
%I Foundation of Computer Science (FCS), NY, USA
Convolutional Neural Networks (CNNs) have become essential tools in automated medical diagnostics, delivering strong performance across a wide range of medical imaging types. In this study, we introduce a 17-layer CNN—made up of 15 convolutional layers and 2 fully connected layers—designed to detect and classify brain tumors, COVID-19, pneumonia, and breast cancer from multimodal images, including MRI scans, chest X-rays, and histopathological slides. The model is first trained on balanced datasets to develop stable and generalizable feature representations, and then fine-tuned on realworld, imbalanced data using a weighted random sampling technique to account for class distribution differences. Cross-validation results show high accuracy across all tasks: 99.97% for brain tumor detection, 99.96% for COVID-19, 98.06% for pneumonia, and 94.87% for breast histopathology. To boost generalization and reduce overfitting, the architecture incorporates batch normalization, transfer learning, and strategic data resampling. Diagnostic performance is further validated using ROC curves, precision–recall metrics, and confusion matrices. By effectively addressing common challenges like class imbalance and domain variability, this work demonstrates the real-world potential of deep learning models to enhance clinical decision-making and support precision medicine.